Paving the way for more effective cancer treatments

From Vision to Reality

The IVD market is the most heavily regulated in the world. Discover how we are navigating this complexity to turn our vision into reality…

2cureX News Blog

The 2cureX News Blog shares insights on IndiTreat® products, strategic developments at 2cureX, and broader topics related to functional precision oncology for cancer patients

IndiTreat®

IndiTreat® is the first CE IVD-marked drug sensitivity test using 3D tumoroids, and delivers true precision in terms of treatment decisions for every cancer patient...

Information for Oncologists and Pathologists

Know more when it matters most:
With our IndiTreat® tests you can finally obtain personalised information, even on the classic compounds for the main chemotherapy backbone for your stage IV mCRC patients.

Information for Patients

You’ve been diagnosed with colorectal cancer, and it is in stage IV. There are rational treatment choices to be made. Which therapy is more likely to impact the tumor? Ask your doctor about IndiTreat®.